Neslihan Akdogan

51PUBLICATIONS
49CO-AUTHORS
Medical bacteriologyPredictive and prognostic markersMedical infection agents (incl. prions)PharmacogenomicsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Jan 10, 2026
Clinical Characteristics, Genomic Sequencing, and Treatment Response of 13 Cases Infected With the Emerging Pathogen, Trichopyhton indotineae, From Türkiye.

Neslihan Akdogan, Mustafa Kamer Kaymak, Cemre Bosnak

|Jun 27, 2025
Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis.

Neslihan Akdogan, Ömer Kutay Mutlu, Erdem Karabulut

|Apr 28, 2025
Poikiloderma With Neutropenia due to Novel USB1 Mutation.

Kerem Balan, Basak Yalici-Armagan, Neslihan Akdogan

|Jul 12, 2024
Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis.

Neslihan Akdogan, Kerem Balan, Basak Yalici Armagan

|Jul 24, 2022
Clonal B-cell proliferations developing in the background of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A case series.

Deniz Ates Ozdemir, Neslihan Akdoğan, Müfide Okay

|Jan 17, 2022
Bizarre Cutaneous Ulcers due to Self-Administered Intravenous Dexketoprofen Trometamol.

Neslihan Akdogan, Gonca Elcin, Sedat Kiraz

Pageof 9

Frequent Collaborators

11 joint publications

Ecem Bostan

10 joint publications

Basak Yalici-Armagan

8 joint publications

Sibel Dogan Gunaydin

8 joint publications

Sibel Ersoy-Evans